Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Formula 5. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of eribulin intermediates via glucose derivatives. Reduces cost and improves scalability for pharmaceutical supply chains globally.
Advanced synthesis of Formula I compounds via palladium-catalyzed cyanation and stereoselective reduction for high-purity pharmaceutical intermediates.
Patent CN113754569A discloses a cost-effective route for Noxastota intermediates using mild carbonyl insertion, offering significant supply chain advantages.
Patent CN114524701B reveals efficient chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates with superior cytotoxicity against QGP-1 tumor cells.